Resveratrol, originally utilized for cancer cells therapy, has revealed advantageous effects versus a lot of degenerative as well as heart diseases from atherosclerosis, hypertension, ischemia/reperfusion, and heart failure to diabetic issues, weight problems, and ageing. The cardioprotective effects of resveratrol relate to its preconditioning-like activity potentiated by its flexible reaction. During preconditioning, small doses of resveratrol can put in adaptive stress feedback, compelling the expression of cardioprotective genes as well as healthy proteins such as heat shock as well as antioxidant proteins. In an analogous way, resveratrol can induce autophagy, one more type of stress adjustment for degrading harmed or long-lived healthy proteins, as the initial line of defence versus oxidative anxiety. Resveratrol's interaction with multiple molecular targets of varied intracellular paths (e.g., activity on sirtuins as well as FoxOs via numerous transcription factors and protein targets) intertwines with those of the autophagic pathway to aid in the changed redox setting after stem cell therapy, which leads to extended survival of cells. The successful application of resveratrol in treatment is based upon its hormetic activity like any like substance: exerting advantageous impacts at lower dosages as well as cytotoxic effects at higher dosages.